Published in Kidney Int on December 01, 1995
Prevalence of occult HBV infection in haemodialysis patients with chronic HCV. World J Gastroenterol (2006) 1.21
Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection. Saudi J Gastroenterol (2009) 1.03
Hepatitis B and C in dialysis units in Kosova. Virol J (2009) 0.99
The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res (2012) 0.90
Occult HCV Infection: The Current State of Knowledge. Iran Red Crescent Med J (2015) 0.83
Profile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in uttarakhand. J Clin Exp Hepatol (2013) 0.82
Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol (2009) 0.79
Occult hepatitis B infection in different high risk patients. Hepat Mon (2012) 0.79
Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients. BMC Nephrol (2012) 0.79
Viral hepatitis in hemodialysis: An update. J Transl Int Med (2015) 0.78
Occult Hepatitis C Virus Infection in Hemodialysis Patients; Single Center Study. Electron Physician (2015) 0.76
Prevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran. Adv Biomed Res (2016) 0.75
Isolated anti-hbc and occult HBV infection in dialysis patients. Nephrourol Mon (2014) 0.75
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol (1999) 5.13
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest (2004) 4.54
Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev (2000) 4.06
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. Lancet (2009) 4.02
Localization and capacity of proton pumps in roots of intact sunflower plants. Plant Physiol (1984) 3.60
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A (2007) 3.60
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci U S A (1998) 3.46
Photosynthetic O2 formation tracked by time-resolved x-ray experiments. Science (2005) 3.35
Gender differences in long-term survival of patients with colorectal cancer. Br J Surg (2001) 3.18
Turnover of carbon isotopes in tail hair and breath CO2 of horses fed an isotopically varied diet. Oecologia (2004) 3.14
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood (2000) 2.70
Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med (2000) 2.43
The NF-M transcription factor is related to C/EBP beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. EMBO J (1993) 2.33
Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. BMJ (1994) 2.31
Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol (1998) 2.17
Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med (1989) 2.15
Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol (1996) 2.14
[The development of a case group concept for patients with mental diseases]. Fortschr Neurol Psychiatr (2003) 2.08
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Gut (2000) 2.08
13C-urea versus 14C-urea breath test: is there still a need for 14C-urea? Nucl Med Commun (1998) 2.06
Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis. EMBO J (2000) 2.05
HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med (1996) 1.99
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer (2003) 1.99
Involvement of a cis-element that binds an H2TF-1/NF kappa B like factor(s) in the virus-induced interferon-beta gene expression. Nucleic Acids Res (1989) 1.97
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Aliment Pharmacol Ther (2011) 1.85
Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiol Scand (1996) 1.85
Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch Dermatol (1990) 1.80
Cloning and heterologous expression of a cDNA encoding 1-deoxy-D-xylulose-5-phosphate reductoisomerase of Arabidopsis thaliana. FEBS Lett (1999) 1.79
Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics (1998) 1.77
The mental health of female sex workers. Acta Psychiatr Scand (2010) 1.75
Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J (1996) 1.74
Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin) Thromb Haemost (1997) 1.73
Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Bone-muscle strength indices for the human lower leg. Bone (2000) 1.65
Fengycin--a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J Antibiot (Tokyo) (1986) 1.64
Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor. Lancet (1997) 1.63
Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet (2009) 1.61
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci (2003) 1.60
Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke (2004) 1.59
DNA analysis in juvenile Huntington disease. Eur J Pediatr (1989) 1.58
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med (1999) 1.58
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol (2005) 1.58
Percutaneous nonangiographic insertion of Hickman catheters in marrow transplant recipients by anesthesiologists and intensivists. Anesth Analg (1997) 1.58
Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer (1996) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
A follow-up report of occupational stress in urban EMT-paramedics. Ann Emerg Med (1989) 1.54
Confocal imaging of glutathione redox potential in living plant cells. J Microsc (2008) 1.54
Autocrine growth induced by kinase type oncogenes in myeloid cells requires AP-1 and NF-M, a myeloid specific, C/EBP-like factor. EMBO J (1992) 1.53
Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med (1998) 1.50
Molecularly cloned simian immunodeficiency virus SIVagm3 is highly divergent from other SIVagm isolates and is biologically active in vitro and in vivo. J Virol (1989) 1.49
Molecular epidemiology of Encephalitozoon cuniculi and first detection of Enterocytozoon bieneusi in faecal samples of pigs. J Eukaryot Microbiol (1996) 1.49
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47
Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease. Int J Cardiol (2000) 1.47
Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Kidney Int (2006) 1.47
IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol (2001) 1.46
High prevalence of hyperhomocysteinemia in critically ill patients. Crit Care Med (2000) 1.46
Long-term results after video-assisted thoracoscopic surgery for first-time and recurrent spontaneous pneumothorax. Ann Thorac Surg (2000) 1.45
Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45
Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest (2007) 1.45
Parents of Children with Asperger Syndrome: What is the Cognitive Phenotype? J Cogn Neurosci (1997) 1.44
Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology (1997) 1.44
Engagement of the T-cell receptor during positive selection in the thymus down-regulates RAG-1 expression. Proc Natl Acad Sci U S A (1992) 1.43
Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol (1991) 1.43
Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol Cell Biol (1999) 1.43
Incorporation of 1-deoxy-D-xylulose into isoprene and phytol by higher plants and algae. FEBS Lett (1997) 1.42
Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem (1995) 1.41
Central venous catheter pinch-off and fracture: recognition, prevention and management. Bone Marrow Transplant (2003) 1.41
Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut (2002) 1.40
Large-scale clustering of cDNA-fingerprinting data. Genome Res (1999) 1.40
Beta-carbolines in chronic alcoholics following trauma. Addict Biol (1996) 1.40
Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation. Gastroenterology (1988) 1.39
[Psychiatrists who took shelter in French-speaking Switzerland from 1933-1945]. Rev Med Suisse Romande (1992) 1.39
Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood (2000) 1.38
Severe pulmonary hypertension reversed by antibiotics in a patient with Whipple's disease. Thorax (1997) 1.38
Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int (1993) 1.37
Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol (1997) 1.37
Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2001) 1.37
Isolation of atypical mycobacteria from tap water in hospitals and homes: is this a possible source of disseminated MAC infection in AIDS patients? J Infect (1995) 1.36
Localization and organization of phenol degradation genes of Pseudomonas putida strain H. Mol Gen Genet (1995) 1.33
The transposable elements resident on the plasmids of Pseudomonas putida strain H, Tn5501 and Tn5502, are cryptic transposons of the Tn3 family. Mol Gen Genet (1998) 1.33
Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med (1999) 1.32
Product inhibition of the hepatitis C virus NS3 protease. Biochemistry (1998) 1.32
Initial experience with technetium-99m HM-PAO brain SPECT. J Nucl Med (1987) 1.30
A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. J Biol Chem (2001) 1.30
Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers. Biochemistry (1996) 1.29
Cardiovascular risk factors in primary care: methods and baseline prevalence rates--the DETECT program. Curr Med Res Opin (2005) 1.29
Distribution of the mevalonate and glyceraldehyde phosphate/pyruvate pathways for isoprenoid biosynthesis in unicellular algae and the cyanobacterium Synechocystis PCC 6714. Biochem J (1998) 1.29
Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol (1998) 1.28
Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants. J Immunol (1982) 1.27
Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol (1998) 1.27
Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest (2004) 1.25
Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens. Immunobiology (1986) 1.24
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation. Antimicrob Agents Chemother (2009) 1.24
Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology (1997) 1.24
Regulation of RAG-1 and CD69 expression in the thymus during positive and negative selection. Eur J Immunol (1994) 1.23
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
The spectrum of pathology in central core disease. Neuromuscul Disord (2002) 1.23
Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology (1987) 1.23